{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:48:27Z","timestamp":1761126507191},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1038\/ncpneuro0093","type":"journal-article","created":{"date-parts":[[2006,5,16]],"date-time":"2006-05-16T16:02:01Z","timestamp":1147795321000},"page":"26-33","source":"Crossref","is-referenced-by-count":20,"title":["Is plasma homocysteine a modifiable risk factor for stroke?"],"prefix":"10.1038","volume":"2","author":[{"given":"Graeme J","family":"Hankey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncpneuro0093_CR1","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1161\/01.ATV.20.7.1704","volume":"20","author":"SH Mudd","year":"2000","unstructured":"Mudd SH et al. (2000) Homocysteine and its disulfide derivatives: a suggested consensus terminology. Arterioscler Thromb Vasc Biol 20: 1704\u20131706","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpneuro0093_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V90.1.1","volume":"90","author":"A D'Angelo","year":"1997","unstructured":"D'Angelo A and Selhub J (1997) Homocysteine and thrombotic disease. Blood 90: 1\u201311","journal-title":"Blood"},{"key":"BFncpneuro0093_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jnutbio.2003.08.010","volume":"15","author":"SJ Moat","year":"2004","unstructured":"Moat SJ et al. (2004) Folate, homocysteine, endothelial function and cardiovascular disease. J Nutr Biochem 15: 64\u201379","journal-title":"J Nutr Biochem"},{"key":"BFncpneuro0093_CR4","first-page":"111","volume":"56","author":"KS McCully","year":"1969","unstructured":"McCully KS (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56: 111\u2013128","journal-title":"Am J Pathol"},{"key":"BFncpneuro0093_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1373\/clinchem.2003.021634","volume":"50","author":"H Refsum","year":"2004","unstructured":"Refsum H et al. (2004) Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 50: 3\u201332","journal-title":"Clin Chem"},{"key":"BFncpneuro0093_CR6","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2165\/00003495-200262040-00005","volume":"62","author":"C Desouza","year":"2002","unstructured":"Desouza C et al. (2002) Drugs affecting homocysteine metabolism: impact on cardiovascular risk. Drugs 62: 605\u2013616","journal-title":"Drugs"},{"key":"BFncpneuro0093_CR7","doi-asserted-by":"crossref","unstructured":"Homocysteine Lowering Trialists' Collaboration (1998) Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 316: 894\u2013898","DOI":"10.1136\/bmj.316.7135.894"},{"key":"BFncpneuro0093_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1046\/j.1365-2796.1999.00430.x","volume":"245","author":"C Van Guldener","year":"1999","unstructured":"Van Guldener C et al. (1999) Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients. J Intern Med 245: 175\u2013183","journal-title":"J Intern Med"},{"key":"BFncpneuro0093_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/jama.291.5.565","volume":"291","author":"JF Toole","year":"2004","unstructured":"Toole JF et al. (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291: 565\u2013575","journal-title":"JAMA"},{"key":"BFncpneuro0093_CR10","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1161\/01.ATV.0000136385.50973.68","volume":"24","author":"GJ Hankey","year":"2004","unstructured":"Hankey GJ et al. (2004) Is there really a power shortage in clinical trials testing the \u201chomocysteine hypothesis\u201d? Arterioscler Thromb Vasc Biol 24: e147","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpneuro0093_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1161\/01.STR.0000150494.91762.70","volume":"36","author":"P Dusitanond","year":"2005","unstructured":"Dusitanond P et al. (2005) Homocysteine-lowering treatment with folic acid, cobalamin and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomised substudy of the VITATOPS trial. Stroke 36: 144\u2013146","journal-title":"Stroke"},{"key":"BFncpneuro0093_CR12","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1161\/01.ATV.0000014588.71807.0A","volume":"22","author":"JD Symons","year":"2002","unstructured":"Symons JD et al. (2002) Hyperhomocysteinemia evoked by folate depletion: effects on coronary and carotid arterial function. Arterioscler Thromb Vasc Biol 22: 772\u2013780","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpneuro0093_CR13","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1161\/01.ATV.0000063607.56590.7F","volume":"23","author":"FM Faraci","year":"2003","unstructured":"Faraci FM (2003) Hyperhomocysteinemia: a million ways to lose control. Arterioscler Thromb Vasc Biol 23: 371\u2013373","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFncpneuro0093_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1161\/01.STR.0000115161.10646.67","volume":"35","author":"FM Faraci","year":"2004","unstructured":"Faraci FM and Lentz SR (2004) Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke 35: 345\u2013347","journal-title":"Stroke"},{"key":"BFncpneuro0093_CR15","doi-asserted-by":"crossref","unstructured":"Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288: 2015\u20132022","DOI":"10.1001\/jama.288.16.2015"},{"key":"BFncpneuro0093_CR16","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","volume":"325","author":"DS Wald","year":"2002","unstructured":"Wald DS et al. (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325: 1202\u20131206","journal-title":"BMJ"},{"key":"BFncpneuro0093_CR17","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/01.STR.0000014607.90464.88","volume":"33","author":"LA Bazzano","year":"2002","unstructured":"Bazzano LA et al. (2002) Dietary intake of folate and risk of stroke in US men and women: NHAMES I Epidemiologic Follow-up Study. Stroke 33: 1183\u20131189","journal-title":"Stroke"},{"key":"BFncpneuro0093_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1161\/01.STR.0000106762.55994.86","volume":"35","author":"K He","year":"2004","unstructured":"He K et al. (2004) Folate, vitamin B6, and B12 intakes in relation to risk of stroke among men. Stroke 35: 169\u2013174","journal-title":"Stroke"},{"key":"BFncpneuro0093_CR19","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1001\/jama.288.16.2023","volume":"288","author":"M Klerk","year":"2002","unstructured":"Klerk M et al. (2002) MTHFR 677C\u2192T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 288: 2023\u20132031","journal-title":"JAMA"},{"key":"BFncpneuro0093_CR20","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0140-6736(05)70152-5","volume":"365","author":"JP Casas","year":"2005","unstructured":"Casas JP et al. (2005) Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet 365: 224\u2013232","journal-title":"Lancet"},{"key":"BFncpneuro0093_CR21","first-page":"263","volume":"351","author":"JC Peterson","year":"1998","unstructured":"Peterson JC and Spence JD (1998) Vitamins and progression of atherosclerosis in hyper-homocyst(e)inaemia. Lancet 351: 263","journal-title":"Lancet"},{"key":"BFncpneuro0093_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0895-7061(99)00180-6","volume":"13","author":"DG Hackam","year":"2000","unstructured":"Hackam DG et al. (2000) What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14\u03bcM\/l. Am J Hypertens 13: 105\u2013110","journal-title":"Am J Hypertens"},{"key":"BFncpneuro0093_CR23","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1097\/01.TP.0000058810.59825.58","volume":"75","author":"R Marcucci","year":"2003","unstructured":"Marcucci R et al. (2003) Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinaemic renal-transplant recipients. Transplantation 75: 1551\u20131555","journal-title":"Transplantation"},{"key":"BFncpneuro0093_CR24","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0140-6736(99)07391-2","volume":"355","author":"EG Vermeulen","year":"2000","unstructured":"Vermeulen EG et al. (2000) Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Lancet 355: 517\u2013522","journal-title":"Lancet"},{"key":"BFncpneuro0093_CR25","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1056\/NEJMoa011364","volume":"345","author":"G Schnyder","year":"2001","unstructured":"Schnyder G et al. (2001) Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 345: 1593\u20131600","journal-title":"N Engl J Med"},{"key":"BFncpneuro0093_CR26","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1001\/jama.288.8.973","volume":"288","author":"G Schnyder","year":"2002","unstructured":"Schnyder G et al. (2002) Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. JAMA 288: 973\u2013979","journal-title":"JAMA"},{"key":"BFncpneuro0093_CR27","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1056\/NEJMoa032845","volume":"350","author":"H Lange","year":"2004","unstructured":"Lange H et al. (2004) Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med 350: 2673\u20132681","journal-title":"N Engl J Med"},{"key":"BFncpneuro0093_CR28","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/S0140-6736(04)16260-0","volume":"363","author":"DA Lawlor","year":"2004","unstructured":"Lawlor DA et al. (2004) Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? Lancet 363: 1724\u20131727","journal-title":"Lancet"},{"key":"BFncpneuro0093_CR29","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/S0140-6736(99)03383-8","volume":"354","author":"NP Dudman","year":"1999","unstructured":"Dudman NP (1999) An alternative view of homocysteine. Lancet 354: 2072\u20132074","journal-title":"Lancet"},{"key":"BFncpneuro0093_CR30","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0140-6736(05)70126-4","volume":"365","author":"GJ Hankey","year":"2005","unstructured":"Hankey GJ and Eikelboom JW (2005) Homocysteine and stroke. Lancet 365: 194\u2013196","journal-title":"Lancet"},{"key":"BFncpneuro0093_CR31","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1161\/01.STR.0000135228.20619.ad","volume":"35","author":"GJ Hankey","year":"2004","unstructured":"Hankey GJ and Eikelboom JW (2004) Folic acid-based multivitamin therapy to prevent stroke: the jury is still out. Stroke 35: 1995\u20131998","journal-title":"Stroke"},{"key":"BFncpneuro0093_CR32","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1056\/NEJM199905133401901","volume":"340","author":"PF Jacques","year":"1999","unstructured":"Jacques PF et al. (1999) The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 340: 1449\u20131454","journal-title":"N Engl J Med"},{"key":"BFncpneuro0093_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.7326\/0003-4819-135-2-200107170-00014","volume":"135","author":"AG Bostom","year":"2001","unstructured":"Bostom AG et al. (2001) Power shortage: clinical trials testing the \u201chomocysteine hypothesis\u201d against a background of folic acid-fortified cereal grain flour. Ann Intern Med 135: 133\u2013137","journal-title":"Ann Intern Med"},{"key":"BFncpneuro0093_CR34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000082788","volume":"19","author":"GJ Hankey","year":"2004","unstructured":"Hankey GJ et al. (2004) Sustained homocyteine-lowering effect over time of folic acid-based multivitamin therapy in stroke patients despite increasing folate status in the population. Cerebrovascular Dis 19: 110\u2013116","journal-title":"Cerebrovascular Dis"},{"key":"BFncpneuro0093_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0140-6736(02)07439-1","volume":"359","author":"EP Quinlivan","year":"2002","unstructured":"Quinlivan EP et al. (2002) Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet 359: 227\u2013228","journal-title":"Lancet"},{"key":"BFncpneuro0093_CR36","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1503\/cmaj.045055","volume":"172","author":"J Robertson","year":"2005","unstructured":"Robertson J et al. (2005) Vitamin B12, homocysteine and carotid plaque in the era of folate fortification of enriched cereal grain products. CMAJ 172: 1569\u20131573","journal-title":"CMAJ"},{"key":"BFncpneuro0093_CR37","unstructured":"Clinical Trials Service Unit, Oxford, UK [ http:\/\/www.ctsu.ox.ac.uk ]"},{"key":"BFncpneuro0093_CR38","unstructured":"B-vitamin Treatment Trialists' Collaboration: Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. Am Heart J, in press"},{"key":"BFncpneuro0093_CR39","doi-asserted-by":"publisher","first-page":"56","DOI":"10.7326\/0003-4819-139-1-200307010-00014","volume":"139","author":"CD Morris","year":"2003","unstructured":"Morris CD and Carson S (2003) Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 139: 56\u201370","journal-title":"Ann Intern Med"},{"key":"BFncpneuro0093_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/bmj.328.7433.211","volume":"328","author":"M Lucock","year":"2004","unstructured":"Lucock M (2004) Is folic acid the ultimate functional food component for disease prevention? BMJ 328: 211\u2013214","journal-title":"BMJ"},{"key":"BFncpneuro0093_CR41","doi-asserted-by":"crossref","first-page":"314","DOI":"10.5694\/j.1326-5377.2004.tb06296.x","volume":"181","author":"GJ Hankey","year":"2004","unstructured":"Hankey GJ et al. (2004) Clinical usefulness of plasma homocysteine in vascular disease. Med J Aust 181: 314\u2013318","journal-title":"Med J Aust"}],"container-title":["Nature Clinical Practice Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0093.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0093","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncpneuro0093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0093.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:24:55Z","timestamp":1684441495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpneuro0093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["BFncpneuro0093"],"URL":"https:\/\/doi.org\/10.1038\/ncpneuro0093","relation":{},"ISSN":["1745-834X","1745-8358"],"issn-type":[{"value":"1745-834X","type":"print"},{"value":"1745-8358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}